Cheryl P. Sanchez

804 total citations
36 papers, 615 citations indexed

About

Cheryl P. Sanchez is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Cheryl P. Sanchez has authored 36 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 11 papers in Pediatrics, Perinatology and Child Health and 7 papers in Oncology. Recurrent topics in Cheryl P. Sanchez's work include Parathyroid Disorders and Treatments (19 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Bone health and treatments (7 papers). Cheryl P. Sanchez is often cited by papers focused on Parathyroid Disorders and Treatments (19 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Bone health and treatments (7 papers). Cheryl P. Sanchez collaborates with scholars based in United States, Spain and Australia. Cheryl P. Sanchez's co-authors include Isidro B. Salusky, William G. Goodman, Beatriz D. Kuizon, Barbara Gales, Jorge A. Ramirez, Robert B. Ettenger, H. Jüppner, Harald Jüppner, Ellen M. Leiferman and Norman J. Wilsman and has published in prestigious journals such as Endocrinology, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Cheryl P. Sanchez

35 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl P. Sanchez United States 15 329 148 131 115 112 36 615
Barbara Mawer United Kingdom 9 172 0.5× 106 0.7× 212 1.6× 104 0.9× 288 2.6× 10 627
Julie Holmes United States 7 888 2.7× 78 0.5× 97 0.7× 132 1.1× 38 0.3× 8 1.0k
Peter E. Gower United Kingdom 16 204 0.6× 54 0.4× 53 0.4× 260 2.3× 60 0.5× 25 652
Claudia Friedl Austria 10 113 0.3× 48 0.3× 45 0.3× 145 1.3× 80 0.7× 19 544
Y Saint‐Hillier France 13 150 0.5× 78 0.5× 110 0.8× 32 0.3× 47 0.4× 35 558
Amélie Ryckewaert France 8 110 0.3× 26 0.2× 59 0.5× 47 0.4× 131 1.2× 17 417
Mette Friberg Hitz Denmark 13 51 0.2× 43 0.3× 126 1.0× 69 0.6× 132 1.2× 30 426
Neil D. Ravin United States 4 62 0.2× 61 0.4× 232 1.8× 100 0.9× 112 1.0× 6 388
O Otsubo Japan 14 174 0.5× 81 0.5× 60 0.5× 55 0.5× 24 0.2× 38 512
Victor Parsons United Kingdom 12 205 0.6× 31 0.2× 59 0.5× 79 0.7× 21 0.2× 28 535

Countries citing papers authored by Cheryl P. Sanchez

Since Specialization
Citations

This map shows the geographic impact of Cheryl P. Sanchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl P. Sanchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl P. Sanchez more than expected).

Fields of papers citing papers by Cheryl P. Sanchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl P. Sanchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl P. Sanchez. The network helps show where Cheryl P. Sanchez may publish in the future.

Co-authorship network of co-authors of Cheryl P. Sanchez

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl P. Sanchez. A scholar is included among the top collaborators of Cheryl P. Sanchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl P. Sanchez. Cheryl P. Sanchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sanchez, Cheryl P., et al.. (2018). Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism. BMC Nephrology. 19(1). 24–24. 12 indexed citations
3.
Sanchez, Cheryl P., et al.. (2016). Inpatient citrate-based hemodialysis in pediatric patients. Pediatric Nephrology. 31(10). 1667–1672. 3 indexed citations
4.
Sanchez, Cheryl P.. (2008). Mineral metabolism and bone abnormalities in children with chronic renal failure. Reviews in Endocrine and Metabolic Disorders. 9(2). 131–137. 18 indexed citations
5.
Sanchez, Cheryl P., et al.. (2007). Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism. Kidney International. 72(5). 582–591. 14 indexed citations
6.
Wehrli, Félix W., Punam K. Saha, Jalal B. Andre, et al.. (2007). Quantitative Microcomputed Tomography Assessment of Intratrabecular, Intertrabecular, and Cortical Bone Architecture in a Rat Model of Severe Renal Osteodystrophy. Journal of Computer Assisted Tomography. 31(2). 320–328. 24 indexed citations
7.
Sanchez, Cheryl P., et al.. (2005). Daily or Intermittent Calcitriol Administration during Growth Hormone Therapy in Rats with Renal Failure and Advanced Secondary Hyperparathyroidism. Journal of the American Society of Nephrology. 16(4). 929–938. 4 indexed citations
8.
Sanchez, Cheryl P., et al.. (2004). Bone elongation in rats with renal failure and mild or advanced secondary hyperparathyroidism. Kidney International. 65(5). 1740–1748. 20 indexed citations
9.
Sanchez, Cheryl P.. (2004). Chronotherapy of high-dose active vitamin D 3 : is evening dosing preferable?. Pediatric Nephrology. 19(7). 722–723. 3 indexed citations
10.
Sanchez, Cheryl P., et al.. (2003). Effects of Thyroparathyroidectomy, Exogenous Calcium, and Short-Term Calcitriol Therapy on the Growth Plate in Renal Failure. Journal of the American Society of Nephrology. 14(1). 148–158. 20 indexed citations
11.
Sanchez, Cheryl P.. (2003). Secondary Hyperparathyroidism in Children with Chronic Renal Failure. Pediatric Drugs. 5(11). 763–776. 17 indexed citations
12.
Sanchez, Cheryl P., Beatriz D. Kuizon, William G. Goodman, et al.. (2002). Growth hormone and the skeleton in pediatric renal allograft recipients. Pediatric Nephrology. 17(5). 322–328. 20 indexed citations
13.
Sanchez, Cheryl P.. (2001). Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease. Seminars in Nephrology. 21(5). 441–450. 14 indexed citations
14.
Sanchez, Cheryl P.. (2000). Modulation of endochondral bone formation: roles of growth hormone, 1,25-dihydroxyvitamin D and hyperparathyroidism. Pediatric Nephrology. 14(7). 646–649. 6 indexed citations
15.
Sanchez, Cheryl P., et al.. (2000). Changes in cyclosporine A levels in pediatric renal allograft recipients receiving recombinant human growth hormone therapy. Transplantation Proceedings. 32(8). 2807–2810. 3 indexed citations
17.
Sanchez, Cheryl P., William G. Goodman, & Isidro B. Salusky. (1999). Prevention of Renal Osteodystrophy in Predialysis Patients. The American Journal of the Medical Sciences. 317(6). 398–398. 13 indexed citations
18.
Equils, Ozlem, et al.. (1999). Penicillium peritonitis in an adolescent receiving chronic peritoneal dialysis. Pediatric Nephrology. 13(9). 771–772. 3 indexed citations
19.
Sanchez, Cheryl P., Isidro B. Salusky, Beatriz D. Kuizon, et al.. (1998). Bone disease in children and adolescents undergoing successful renal transplantation. Kidney International. 53(5). 1358–1364. 108 indexed citations
20.
Melez, Kathleen A., et al.. (1995). Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole.. PubMed. 14(12). 1110–3. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026